Medicure Inc.
MCUJF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | -0.54 | -0.08 | 0.02 |
| FCF Yield | -4.87% | -5.64% | 9.50% | 20.00% |
| EV / EBITDA | -11.55 | -162.64 | -70.79 | 1.42 |
| Quality | ||||
| ROIC | -7.49% | -3.89% | -3.30% | -2.95% |
| Gross Margin | 33.99% | 51.51% | 51.84% | 58.37% |
| Cash Conversion Ratio | 0.37 | 0.93 | -0.95 | -4.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.54% | -0.03% | -1.89% | -1.70% |
| Free Cash Flow Growth | 28.81% | -211.13% | -64.75% | 313.91% |
| Safety | ||||
| Net Debt / EBITDA | 4.77 | 63.98 | 792.50 | -3.01 |
| Interest Coverage | -655.00 | 0.00 | 0.00 | -12.20 |
| Efficiency | ||||
| Inventory Turnover | 1.38 | 0.81 | 0.68 | 0.75 |
| Cash Conversion Cycle | -17.19 | -57.86 | -77.92 | -89.65 |